---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-039315"
form_type: "8-K/A"
ticker: "ADTX"
cik: "0001726711"
company_name: "Aditxt, Inc."
filed_at: "2024-05-03T23:59:59+00:00"
generated_at: "2026-06-02T23:13:46.176852+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Aditxt reinstates merger with Evofem via Fourth Amendment, pays $1M, extends deadline to July 15

## Summary
- Aditxt and Evofem reinstate Merger Agreement via Fourth Amendment dated May 2, 2024, nullifying prior termination notice.
- Aditxt makes $1M initial payment; commits to raise up to $2.5M by July 1 for Evofem Series F-1 Preferred Stock.
- Termination deadline extended from May 8 to July 15, 2024; 'no shop' clause removed, Evofem may negotiate other deals.
- Aditxt must raise $1.5M by June 17 and $1M by July 1, or Evofem can terminate the Merger Agreement.

## SEC filing metadata
- accession: 0001213900-24-039315
- form_type: 8-K/A
- ticker: ADTX
- cik: 0001726711
- company_name: Aditxt, Inc.
- filed_at: 2024-05-03T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.02, 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1726711/000121390024039315/0001213900-24-039315-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1726711/000121390024039315/ea0205208-8ka1_aditxt.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-039315
- JSON: https://secwatch.observer/filing/0001213900-24-039315.json
- Plain text: https://secwatch.observer/filing/0001213900-24-039315.txt

## Key facts
- Material Agreements
  Aditxt, Inc. terminated Agreement and Plan of Merger with Evofem Biosciences, Inc..
  - Action: termination
  - Agreement: merger
  - Counterparty: Evofem Biosciences, Inc.
  source text: the Company received notice from Evofem (the “ Termination Notice ”) that Evofem was exercising its right to terminate the Merger Agreement as a result of the Company’s failure to provide the Initial Parent Equity Investment (as defined in the Merger Agreement, as amended)
  evidence_url: https://www.sec.gov/Archives/edgar/data/1726711/000121390024039315/0001213900-24-039315-index.htm
- Material Agreements
  Aditxt, Inc. amended Reinstatement and Fourth Amendment to the Merger Agreement with Evofem Biosciences, Inc. valued at $1,000,000 (effective 2024-05-02).
  - Action: amendment
  - Agreement: merger
  - Counterparty: Evofem Biosciences, Inc.
  - Value: $1,000,000
  - Effective: 2024-05-02
  source text: On May 2, 2024, the Company, Adifem, Inc. f/k/a Adicure, Inc. and Evofem Biosciences, Inc. (“Evofem”) entered into the Reinstatement and Fourth Amendment to the Merger Agreement (the “ Fourth Amendment ”)
  evidence_url: https://www.sec.gov/Archives/edgar/data/1726711/000121390024039315/0001213900-24-039315-index.htm
- Material Agreements
  Aditxt, Inc. entered into Agreement and Plan of Merger with Evofem Biosciences, Inc..
  - Agreement: merger
  - Counterparty: Evofem Biosciences, Inc.
  source text: the Company entered into an Agreement and Plan of Merger (the “ Merger Agreement ”) with Adifem, Inc. f/k/a Adicure, Inc., a Delaware corporation and wholly owned subsidiary of the Company (“ Adifem ”) and Evofem Biosciences, Inc., a Delaware corporation (“ Evofem ”)
  evidence_url: https://www.sec.gov/Archives/edgar/data/1726711/000121390024039315/0001213900-24-039315-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.